ArticlePathology oncology research : POR2022

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy.

Yuxiang Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.